Related references
Note: Only part of the references are listed.Ron Kinase Transphosphorylation Sustains MET Oncogene Addiction
Silvia Benvenuti et al.
CANCER RESEARCH (2011)
Synthetic Lethality Screens Reveal RPS6 and MST1R as Modifiers of Insulin-like Growth Factor-1 Receptor Inhibitor Activity in Childhood Sarcomas
Jenny C. Potratz et al.
CANCER RESEARCH (2010)
BMS-777607, a Small-Molecule Met Kinase Inhibitor, Suppresses Hepatocyte Growth Factor-Stimulated Prostate Cancer Metastatic Phenotype In vitro
Yao Dai et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily
Gretchen M. Schroeder et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells
Weiguo Liu et al.
CARCINOGENESIS (2008)
A role for VEGF as a negative regulator of pericyte function and vessel maturation
Joshua I. Greenberg et al.
NATURE (2008)
The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression
Ryan M. Thomas et al.
CANCER RESEARCH (2007)
Tyrosine kinase receptor RON in human pancreatic cancer - Expression, function, and validation as a target
E. Ramsay Camp et al.
CANCER (2007)
Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member
Jennifer M. O'Toole et al.
CANCER RESEARCH (2006)
Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells
Todd W. Bauer et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor
BE Peace et al.
EXPERIMENTAL CELL RESEARCH (2003)
Large-scale analysis of the yeast proteome by multidimensional protein identification technology
MP Washburn et al.
NATURE BIOTECHNOLOGY (2001)
Cross-talk between the proto-oncogenes Met and Ron
A Follenzi et al.
ONCOGENE (2000)
Share Paper
